Hemostemix Inc.
HEM.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -568.10K | -1.88M | -420.20K | -165.30K | -895.10K |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.90K | -35.20K | -233.80K | 135.70K | 496.50K |
| Change in Net Operating Assets | 45.30K | 1.08M | -1.46M | -549.40K | 633.70K |
| Cash from Operations | -585.70K | -836.30K | -2.11M | -579.10K | 235.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -200.00 | 0.00 | 0.00 | -101.40K |
| Cash from Investing | -- | -200.00 | 0.00 | 0.00 | -101.40K |
| Total Debt Issued | -- | 749.80K | -- | -- | -- |
| Total Debt Repaid | -- | -1.25M | -- | -- | -- |
| Issuance of Common Stock | 304.00K | 1.19M | 3.38M | 515.10K | 67.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 218.60K | 496.10K | 2.46M | 372.30K | 47.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -367.10K | -340.40K | 346.80K | -206.80K | 180.80K |